Kepler Capital Remains a Sell on Galapagos (0JXZ)

TipRanksDec 11 09:36 · Ratings

Cautious Hold Rating for Galapagos: Unproven Efficacy and Logistical Concerns in CD19 CAR-T Programs

TipRanksDec 10 14:05 · Ratings

Galapagos Announced New Results From Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, In Patients With Relapsed/Refractory Non-Hodgkin Lymphoma; Demonstrated High Antitumor Activity And An Encouraging Safety Profile In All NHL Subtypes...

BenzingaDec 8 04:24

Galapagos' Innovative CAR T-Cell Therapy Shows Promise

TipRanksDec 8 02:02

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

GlobeNewswireNov 6 05:01

Analysts' Opinions Are Mixed on These Healthcare Stocks: Haleon PLC Sponsored ADR (HLN), Insmed (INSM) and Galapagos (GLPG)

TipRanksNov 5 14:31 · Ratings